Pathogenic Thyroglobulin Peptides as Model Antigens: Insights on the Induction and Maintenance of Autoimmune Thyroiditis

References

• Carayanniotis G., Rao V. P. Searching for pathogenic epitopes in thyroglobulin: parameters and caveats. Immunol. Today 1997; 18: 83–88
   PubMedGoogle Scholar
• Roitt I. M., Doniach D., Campell P. N., Hudson R. V. Autoantibodies in Hashimoto's disease (lymphadenoid goitre). Lancet 1956; 2: 820–821
   Web of Science ®Google Scholar
• Rose N. R., Witebsky E. Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thryroid extract. J. Immunol 1956; 76: 417–427
   PubMed Web of Science ®Google Scholar
• Di Lauro R., Obici S., Condliffe D., Ursini V. M., Musti A., Moscatelli C., Avvedimento V. E. The sequence of 967 amino acids at the carboxyl-end of rat thyroglobulin. Eur. J. Biochem 1985; 148: 7–11
   PubMedGoogle Scholar
• Caturegli P., Vidalain P. O., Vali M., Aguilera L. A., GalavizRose N. R. Cloning and characterization of murine thyroglobulin cDNA. Clin. Immunol. Immunopathol 1997; 85: 221–226
   PubMedGoogle Scholar
• Kim P. S., Hossain S. A.Y., Park N., Lee I. S., Yoo E., Arvan P. A single amino-acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases. Proc. Natl. Acad. Sci. USA 1998; 95: 9909–9913
   PubMedGoogle Scholar
• Malthiery Y., Lissitzky S. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur. J. Biochem 1987; 165: 491–498
   PubMedGoogle Scholar
• Mercken L. M., Simons J., Swillens S., Massaer M., Vassart G. Primary structure of bovine thyroglobulin deduced from the sequence of its 8,431-base complementary DNA. Nature 1985; 316: 647–651
   PubMed Web of Science ®Google Scholar
• Dunn J. T. Thyroglobulin, hormone synthesis and thyroid disease. Eur. J. Endocrinol 1995; 32: 603–604
   Google Scholar
• Champion B. R., Rayner D. C., Byfield P. G., Page K. R., Jo C. T., Chan Roitt I. M. Critical role of iodination for T cell recognition of thyroglobulin in experimental murine thyroid autoimmunity. J. Immunol 1987; 139: 3665–3670
   PubMed Web of Science ®Google Scholar
• Champion B. R., Page K. R., Parish N., Rayner D. C., Dawe K., Biswas G., HughesCooke A., Geysen M., Roitt I. M. Identification of a thyroxme-containing self epitope of thyroglobulin which triggers thyroid autoreactive T cells. J. Exp. Med 1991; 174: 363–370
   PubMed Web of Science ®Google Scholar
• Hutchings P. R., Cooke A., Dawe K., Champion B. R., Geysen M., Valerio R., Roitt I. M. A thyroxine-containing peptide can induce murine experimental autoimmune thyroiditis. J. Exp. Med 1992; 175: 869–872
   PubMed Web of Science ®Google Scholar
• Dawe K. I., Hutchings P. R., Geysen M., Champion B. R., Cooke A., Roitt I. M. Unique role of thyroxine in T cell recognition of a pathogenic peptide in experimental autoimmune thyroiditis. Eur. J. Immunol 1996; 26: 768–772
   PubMedGoogle Scholar
• Kong Y. M., Mc D. J., CormickWan Q., Motte R. W., Fuller B. E., Giraldo A. A., David C. S. Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination. J. Immunol 1995; 155: 5847–5854
   PubMed Web of Science ®Google Scholar
• Wan Q., Motte R. W., Mc D. J., CormickFuller B. E., Giraldo A. A., David C. S., Kong Y. M. Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis: role of MHC class II. Clin. Immunol. Immunopathol 1997; 85: 187–194
   PubMedGoogle Scholar
• Rao V. P., Balasa B., Carayanniotis G. Mapping of thyroglobulin epitopes: Presentation of a 9mer pathogenic peptide by different mouse MHC class II isotypes. Immunogenetics 1994; 40: 352–359
   PubMedGoogle Scholar
• Carayanniotis G., Chronopoulou E., Rao V. P. Distinct genetic pattern of mouse susceptibility to thyroiditis induced by a novel thyroglobulin peptide. Immunogenetics 1994; 39: 21–28
   PubMed Web of Science ®Google Scholar
• Rayner D. C., Champion B. R., Cooke A. Thyroglobulin as autoantigen and tolerogen. Monoclonal antibodies and peptide therapy in autoimmune diseases, J. F. Bach. Marcel Dekker, Inc., New York 1993; 359–376
   Google Scholar
• Wan Q., Mc D. J., CormickDavid C. S., Kong Y. M. Thyroglobulin peptides from specific primary hormonogenic sites can generate cytotoxic T cells and serve as target autoantigens in experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol 1998; 86: 110–114
   PubMedGoogle Scholar
• Kong Y. M., Lomo L. C., Motte R. W., Giraldo A. A., Baisch J., Strauss G., Hammerling G. J., David C. S. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: Definitive association with HLA-DRB10301 (DR3) gene. J. Exp. Med 1996; 184: 1167–1172
   PubMed Web of Science ®Google Scholar
• Wan Q., Shah R., Giraldo A. A., David C. S., Kong Y. M. HLA-DQ8 transgenic class II-negative mice develop autoimmune thyroiditis after induction with human thyroglobulin. Human Immunol. 2000, Submitted.
   Google Scholar
• McLntosh R. S., Watson P. F., Pickerill R., Davies R., Weetman A. P. No restriction of intrathyroidal T cell receptor Va families in the thyroid of Graves' disease. Clin. Exp. Immunol 1993; 91: 147–152
   PubMedGoogle Scholar
• Caso E., Mc Peláez A. M., GregorBanga J. P. A polyclonal T cell repertoire of V-alpha and V-beta T cell receptor gene families in intrathyroidal T lymphocytes of Graves' disease patients. Scand. J. Immunol 1995; 41: 141–147
   PubMedGoogle Scholar
• Martin A., Barbesino G., Davies T. F. T-cell receptors and autoimmune thyroid disease-Signposts for T-cell-antigen driven diseases. Intern. Rev. Immunol 1999; 18: 111–140
   PubMedGoogle Scholar
• Matsuoka N., Bernard L. A., Concepcion L. A., Graves P. N., Ben A., NunGraves P., Davies T. F. T cell receptor V beta gene expression in the autoimmune thyroiditis of NOD mice. J. Immunol 1993; 151: 1691–1701
   PubMed Web of Science ®Google Scholar
• Sugihara S., Fujiwara H., Shearer G. M. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. Characterization of thyroiditis-inducing T cell lines and clones derived from thyroid lesions. J. Immunol 1993; 150: 683–694
   PubMedGoogle Scholar
• Matsuoka N., Unger P., Ben A., NunGraves P., Davies T. F. Thyroglobulin-induced murine thyroiditis assessed by intrathyroidal T cell receptor sequencing. J. Immunol 1994; 154: 2562–2568
   Google Scholar
• Mc R. W., MurrayHoffman R. W., Tang H., Braley H. Mullen. T cell receptor V/3 usage in murine experimental autoimmune thyroiditis. Cell Immunol 1996; 172: 1–9
   PubMedGoogle Scholar
• Nakashima M., Kong Y. M., Davies T. F. The role of T cells expressing TcR Vβ in autoimmune thyroiditis induced by transfer of mouse thyroglobulin-activated lymphocytes: identification of two common CDR3 motifs. Clin. Immunol. Immunopathol 1996; 80: 204–210
   PubMedGoogle Scholar
• Rao V. P., Russell R. S., Carayanniotis G. Recruitment of multiple Vβ genes in the TCR repertoire against a single pathogenic thyroglobulin epitope. Immunology 1997; 91: 623–627
   PubMedGoogle Scholar
• Lomo L. C., Zhang F., Mc D. J., CormickGiraldo A. A., David C. S., Kong Y. M. Flexibility of the thyroiditogenic T cell repertoire for murine autoimmune thyroiditis in CD8-deficient (β2m-/-) and T cell receptor Vβc congenic mice. Autoimmunity 1998; 27: 127–133
   PubMed Web of Science ®Google Scholar
• Creemers P., Rose N. R., Kong Y. M. Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J. Exp. Med 1983; 157: 559–571
   PubMedGoogle Scholar
• Lomo L. C., Motte R. W., Giraldo A. A., Nabozny G. H., David C. S., Rimm I. J., Kong Y. M. Vβ8.2 transgene expression interferes with development of experimental autoimmune thyroiditis in CBA k/q but not k/k mice. Cell Immunol 1996; 168: 297–301
   PubMedGoogle Scholar
• Rao V. P., Carayanniotis G. Contrasting immunopathogenic properties of highly homologous peptides from rat and human thyroglobulin. Immunology 1997; 90: 244–249
   PubMedGoogle Scholar
• Gammon G., Shastri N., Cogswell J., Wilbur S., Sadegh S., NasseriKrzych U., Miller A., Sercarz E. The choice of T cell epitopes utilized on a protein antigen depends on multiple factors distant from as well as at the determinant site. Immunol. Rev 1987; 98: 53–73
   PubMed Web of Science ®Google Scholar
• Rao V. P., Kajon A. E., Spindler K. R., Carayanniotis G. Involvement of epitope mimicry in potentiation but not initiation of autoimmune disease. J. Immunol 1999; 162: 5888–5893
   PubMedGoogle Scholar
• Ball A. O., Williams M. E., Spindler K. R. Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function. J. Virol 1988; 62: 3947–3957
   PubMedGoogle Scholar
• Mc B. L., RaeNikcevich K. M., Karpus W. J., Hurst S. D., Miller S. D. Differential recognition of peptide analogs by naive versus activated PLP 139–151-specific CD4+ T cells. J. Neuroimmunol 1995; 60: 17–28
   PubMedGoogle Scholar
• Carrizosa A. M., Nicholson L. B., Farzan M., Southwood S., Sette A., Sobel R. A., Kuchroo V. K. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J. Immunol 1998; 161: 3307–3314
   PubMed Web of Science ®Google Scholar
• Damle N. K., Klussman K., Linsley P. S., Aruffo A. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J. Immunol 1992; 148: 1985–1992
   PubMed Web of Science ®Google Scholar
• Croft M., Bradley L. M., Swain S. L. Naive versus memory CD4 T cell response to antigen: Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol 1994; 152: 2675–2685
   PubMed Web of Science ®Google Scholar
• Luqman M., Bottomly K. Activation requirements for CD4+ T cells differing in CD45R expression. J. Immunol 1992; 149: 2300–2306
   PubMedGoogle Scholar
• Volpé R., Row V. V., Ezrin V. Circulating viral and thyroid antibodies in subacute thyroiditis. J. Clin. Endocrinol. Metabol 1967; 27: 1275–1284
   PubMed Web of Science ®Google Scholar
• Tomer Y., Davies T. F. Infection, thyroid disease and autoimmunity. Endocr. Rev 1993; 14: 107–120
   PubMed Web of Science ®Google Scholar
• Tonooka N., Leslie G. A., Greer M. A., Olson J. C. Lymphoid thyroiditis following immunization with group A streptococcal vaccine. Am. J. Pathol 1978; 92: 681–687
   PubMedGoogle Scholar
• Valtonen V. V., Ruutu P., Vans K. Serological evidence for the role of bacterial infections in the pathogenesis of thyroid disease. Acta Med. Scand 1986; 219: 105–111
   PubMedGoogle Scholar
• Lanzavecchia A. How can cryptic epitopes trigger autoimmunity. J. Exp. Med 1995; 181: 1945–1948
   PubMed Web of Science ®Google Scholar
• Simitsek P. D., Campbell D. G., Lanzavecchia A., Fairweather N., Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med 1995; 181: 1957–1963
   PubMedGoogle Scholar
• Amigorena S., Bonnerot C. Role of B-cell and Fc receptors in the selection of T-cell epitopes. Curr. Opin. Immunol 1998; 10: 88–92
   PubMedGoogle Scholar
• Stockinger B. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes. Eur. J. Immunol 1992; 22: 1271–1278
   PubMed Web of Science ®Google Scholar
• Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Amu. Rev. Immunol 1997; 15: 821–850
   PubMed Web of Science ®Google Scholar
• Lehmann P. V., Sercarz E. E., Forsthuber T., Dayan C. M., Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993; 14: 203–208
   PubMedGoogle Scholar
• Dai Y., Carayanniotis K. A., Eliades P., Lymberi P., Shepherd P., Kong Y. M., Carayanniotis G. Enhancing or suppressive effects of antibodies on processing of a pathogenic T-cell epitope in thyroglobulin. J. Immunol 1999; 162: 6987–6992
   PubMedGoogle Scholar
• Ozaki S., Berzofsky J. A. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity. J. Immunol 1987; 138: 4133–4142
   PubMedGoogle Scholar
• Berzofsky J. A. T-B reciprocity. An la-restricted epitope-specific circuit regulating T cell-B cell interaction and antibody specificity. Surv. Immunol Res 1983; 2: 223–229
   PubMedGoogle Scholar
• Tomer Y. Anti-thyroglobulin amoantibodies in autoimmune thyroid diseases: cross-reactive or pathogenic. Clin. Immunol. Immunopathol 1997; 82: 3–11
   PubMedGoogle Scholar
• Weetman A. P., Black C. M., Cohen S. B., Tomlinson R., Banga J. P., Reimer C. B. Affinity purification of IgG subclasses and the distribution of thyroid auto-antibody reactivity in Hashimoto's thyroiditis. Scand. J. Immunol 1989; 30: 73–82
   PubMedGoogle Scholar
• Weetman A. P., Cohen S. The IgG subclass distribution of thyroid autoantibodies. Immunol. Let 1986; 13: 335–341
   PubMedGoogle Scholar
• Devey M. E., Bleasdale K. M., BarrMc S. M., LachlanBradbury J., Clark F., Young E. T. Serial studies on the affinity and heterogeneity of human autoanti-bodies to thyroglobulin. Clin. Exp. Immunol 1989; 77: 191–195
   PubMed Web of Science ®Google Scholar
• Kuppers R. C., Hu Q., Rose N. R. Mouse thyroglobulin: conservation of sequence homology in C-terminal immunogenic regions of thyroglobulin. Autoimmunity 1996; 23: 175–180
   PubMed Web of Science ®Google Scholar